Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Operating Activities:
Net income (loss)	$ (6,502)	$ (17,333)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	910	868
Amortization	318	687
Non cash amortization of right-of-use asset and liability	(288)	225
Charge for lower of cost or net realizable value inventories	105	60
Impairment of right-of-use asset	0	660
Impairment of intangibles including goodwill	0	8,714
Gain on disposal of property and equipment	(23)	(133)
Share based compensation expense	1,009	574
Gain from equity method investment	0	(41)
Gain on extinguishment of debt	(2,955)	0
Changes in operating assets and liabilities:
Accounts receivable	(3,045)	859
Unbilled revenue	(1,899)	2,101
Income tax refund receivable\payable	1,284	(1,262)
Inventories	(875)	27
Prepaid expenses and other current assets	(547)	(147)
Other assets	51	(2)
Accounts payable	3,572	(1,259)
Accrued expenses	898	(220)
Deferred revenue	55	16
Net cash used in operating activities	(7,510)	(3,824)
Investing Activities:
Proceeds from promissory note receivable	3,775	2,600
Loan repayments from equity method investee	0	41
Purchases of property and equipment	(300)	(608)
Disposals of property and equipment	44	361
Net cash provided by investing activities	3,519	2,394
Financing Activities:
Change in bank line of credit	(750)	2,800
Proceeds from note payable	0	6,372
Guaranteed payments for acquisition of business	0	(667)
Payments on financing lease obligations	(484)	(388)
Payments on notes payable	(1,194)	(2,223)
Proceeds from sale of common stock	899	2,109
Proceeds from stock options exercised	89	206
Net cash (used in) provided by financing activities	(1,440)	8,209
Net (decrease) increase in cash, cash equivalents and restricted cash	(5,431)	6,779
Cash, cash equivalents and restricted cash at beginning of year	8,373	1,594
Cash, cash equivalents and restricted cash at end of year	$ 2,942	$ 8,373